Citadel Advisors’s Tenaya Therapeutics TNYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.7K | Buy |
+24,062
| New | +$14.7K | ﹤0.01% | 5661 |
|
|
2025
Q1 | – | Sell |
-438,886
| Closed | -$628K | – | 6924 |
|
|
2024
Q4 | $628K | Sell |
438,886
-1,896,265
| -81% | -$2.71M | ﹤0.01% | 3758 |
|
|
2024
Q3 | $4.51M | Buy |
2,335,151
+192,078
| +9% | +$371K | ﹤0.01% | 1838 |
|
|
2024
Q2 | $6.64M | Sell |
2,143,073
-104,443
| -5% | -$324K | ﹤0.01% | 1468 |
|
|
2024
Q1 | $11.8M | Buy |
2,247,516
+246,311
| +12% | +$1.29M | ﹤0.01% | 1200 |
|
|
2023
Q4 | $6.48M | Sell |
2,001,205
-104,672
| -5% | -$339K | ﹤0.01% | 1493 |
|
|
2023
Q3 | $5.37M | Buy |
2,105,877
+1,090,819
| +107% | +$2.78M | ﹤0.01% | 1568 |
|
|
2023
Q2 | $5.96M | Sell |
1,015,058
-84,022
| -8% | -$493K | ﹤0.01% | 1587 |
|
|
2023
Q1 | $3.13M | Sell |
1,099,080
-32,991
| -3% | -$94K | ﹤0.01% | 2148 |
|
|
2022
Q4 | $2.28M | Buy |
1,132,071
+914,733
| +421% | +$1.84M | ﹤0.01% | 2459 |
|
|
2022
Q3 | $631K | Buy |
217,338
+168,378
| +344% | +$489K | ﹤0.01% | 3858 |
|
|
2022
Q2 | $276K | Buy |
+48,960
| New | +$276K | ﹤0.01% | 4706 |
|